NOVUS THERAPTCS Revenue, Profits - NVUS Quarterly Income Statement

Add to My Stocks
$4.85 $0 (0%) NVUS stock closing price Sep 20, 2018 (Closing)

Financial analysis of NOVUS THERAPTCS involves more than just checking the NOVUS THERAPTCS stock price, by looking at the financial statements of the company in detail. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from - to - and how operating and non operating activities have impacted the NVUS stock. The NOVUS THERAPTCS profit and loss statement for 2018 Q2 shows a net profit of $-3.19M. Profits for last year was $-2.81M. Apart from this an investor should also check NOVUS THERAPTCS assets and NOVUS THERAPTCS free cash flow.

View and download details of revenue and profits for NOVUS THERAPTCS for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
NOVUS THERAPTCS Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
Research & Development Expense1.33M1.09M----1.04M6.16M9.89M7.93M
Selling General & Admin Expense1.86M1.69M-1.06M2.44M6.13M3.58M2.73M3.14M3.68M3.54M
Income Before Depreciation Depletion Amortization-3.19M-2.79M--2.96M-6.66M-3.89M-3.77M-9.3M-13.57M-11.48M
Depreciation Depletion Amortization----------
Non Operating Income--0.01M-0.01M-0.01M------
Interest Expense----------
Provision for Income Taxes----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-3.19M-2.81M-2.11M-2.97M-6.66M-3.86M-3.74M-9.27M-13.53M-11.43M
Extraordinary Items & Discontinued Operations----------
NOVUS THERAPTCS Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS9.41M7.75M4.68M6.94M4.16M--2.52M2.51M2.51M
Average Shares used to compute Basic EPS9.41M7.75M4.68M6.94M4.16M--2.52M2.51M2.51M
Income Before Nonrecurring Items-3.19M-2.81M-2.11M-2.97M-6.66M---9.27M-13.53M-11.43M
Income from Nonrecurring Items----------
NOVUS THERAPTCS Earnings Per Share Basic Net
NOVUS THERAPTCS Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.34-0.36-0.05-0.43-1.32---3.69-5.40-4.59
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on NOVUS THERAPTCS stock analysis. It helps to look at the following income statement items:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: NOVUS THERAPTCS revenue chart, implies that the company is growing. It has not been the case with NOVUS THERAPTCS. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like NOVUS THERAPTCS try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The NVUS financials along with NOVUS THERAPTCS historical stock prices provide a lot of details about the firm.

NOVUS THERAPTCS Income Statement - Key Financial Ratios